Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04350073 · ClinicalTrials.gov registry record
Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 65
- Enrollment target
NCT04350073: Completed study, sponsored by Duke University.
NCT04350073 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04350073 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This current proposal evaluates the Longitudinal Energy Expenditure and Metabolic Effects in Patients with COVID-19 (LEEP-COVID) to understand, guide and optimize our metabolic and nutritional care of these high risk patients. As no data exist for the metabolic effects of COVID-19 patients, this data is urgently needed and essential to assist in the care of COVID-19 patients worldwide. We are uniquely positioned at Duke to perform this research, as we are the only US center with 2 of the FDA-approved devices in existence currently capable of collecting this vital data to guide the care of COVID-19 patients worldwide.
Primary Outcome
The amount of CO2 produced combined with O2 consumed is called the REE (kcal/day) and is measured by the gases exchanged at the mouth.
Interventions
- DEVICE Q-NRG Metobolic Cart Device
- DEVICE MuscleSound Ultrasound
- DEVICE Multifrequency Bioimpedance Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2022-08-22 |
What the finished NCT04350073 record still lists
NCT04350073 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Q-NRG Metobolic Cart Device is the first listed.
NCT04350073 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04350073 about?
NCT04350073 is a clinical study titled "Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)". This current proposal evaluates the Longitudinal Energy Expenditure and Metabolic Effects in Patients with COVID-19 (LEEP-COVID) to understand, guide and optimize our metabolic and nutritional care of these high risk patients. As no data exist for the metabolic effects of COVID-19 patients, this dat...
What is the current status of trial NCT04350073?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2020-04-20. Estimated completion is 2022-08-22.
What interventions are being tested in trial NCT04350073?
The interventions under investigation include: Q-NRG Metobolic Cart Device (DEVICE), MuscleSound Ultrasound (DEVICE), Multifrequency Bioimpedance Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT04350073?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI